CHEK1 and Miyoshi myopathy: In association with the poor outcome of MM patients with high CHK1/WEE1 expression following anti-CD38 MoAb treatment, we identified that patients with high CHK1 expression exhibit a significant lower percentage of NK cells in the bone marrow whereas patients with high WEE1 expression display a significant higher percentage of regulatory T cells.